CL·Colgate-Palmolive Company
CL|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $0.93 | - | - |
| Q2'26 | $0.98 | $0.99 | +1.5% |
| Q1'26 | $0.96 | $0.97 | +1.4% |
| Q4'25 | $0.94 | $0.95 | +1.1% |
| Q3'25 | $0.89 | $0.91 | +2.4% |
| Q2'25 | $0.89 | $0.92 | +2.8% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $5.5B | - | - |
| Q2'26 | $5.5B | $5.4B | -2.9% |
| Q1'26 | $5.3B | $5.3B | -0.2% |
| Q4'25 | $5.3B | $5.2B | -0.8% |
| Q3'25 | - | $5.1B | - |
| Q2'25 | - | $5.1B | - |
CL|Monthly Returns
Market Data
CL Stock Snapshot
- Market cap
- 69.66B
- P/E ratio
- 34.2
- Day range
- $86.79 – $87.84
- News sentiment
- 56/100 · Neutral
- Analyst target
- $98.95 (+13.1%)
- Consensus
- Buy · 32 analysts
CL is on the weaker side of its setup, with little confirmation for a reversal yet. Earnings and guidance carry more weight than macro data at this capitalisation.
Reverse DCF
What growth is priced into CL?
At today's price, Colgate-Palmolive Company needs to grow free cash flow about -3.3% a year for the next 10 years to justify its valuation at a 6.24% cost of capital. Over its actual history it has compounded free cash flow at 2.5% a year, so the market is asking for 5.8 percentage points below its own delivered rate. On that basis CL looks priced below what its own growth record supports.
- Implied FCF growth
- -3.3%
- Historical FCF CAGR
- 2.5%
- Growth gap
- -5.8 pts
- Verdict
- CHEAP
- Discount rate (WACC)
- 6.24%
- Beta
- 0.35
Behaviour On Record
What CL's own history says about today's numbers
- Realized volatility (21d)
- 15.1% 43rd pct
- Below its peak
- -19.6%
- vs 200-day average
- -0.6%
- Up days (1y)
- 51%
Colgate-Palmolive Company is currently running 15.1% annualised volatility over the last 21 sessions. Measured against CL's own 13 years of daily returns rather than a market-wide average, that is the 43rd percentile — close to its own typical level, against a typical reading of 16.0%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
CL is trading -19.6% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -15.8%, and the deepest was -25.3% in 2018. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits -0.6% from its 200-day moving average. Against every other day in its history, that gap ranks at the 41st percentile — close to the gap it normally carries. Over the past year CL closed higher on 51% of sessions, and it is currently 1 session into a falling streak.
On September specifically: over 13 years of records, CL finished the month higher 4 of 13 times, with a median return of -1.4% and an average of -1.8%. Its strongest month historically has been November at +2.4% on average, its weakest September at -1.8%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: CL has opened more than 2% away from the prior close in 27 of 3,268 sessions (0.8% of the time), with the largest gaps running +4.7% and -6.4%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, CL moved an average of 1.9% in the session after earnings, closing higher 1 of those 3 times, with a median move of -0.8% and a largest of +2.9%.
All figures computed from 3,269 daily closes between 2013-09-19 and 2026-09-18, split-adjusted, recomputed daily. Percentiles are against CL's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of CL's sector?
Colgate-Palmolive Company sits in the Consumer Staples sector, currently ranked 6th of 11 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #6 of 11
- Sector state
- Improving
- Sector rotation score
- 60
Analyst Rating Changes
Are analysts turning bullish or bearish on CL?
RBC Capital most recently reiterated its rating on Colgate-Palmolive Company to Outperform on Sep 8, 2026 with a price target of $104. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- RBC Capital — Outperform
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
CL Competitive Positioning
- CLyou're hereColgate-Palmolive Company$69.7B+0.02%
- KVUEKenvue Inc.$34.4B+0.11%
- ELThe Estée Lauder Companies Inc.$34.0B0.00%
- KMBKimberly-Clark Corporation$32.6B+0.36%
- CHDChurch & Dwight Co., Inc.$22.5B+0.04%
- CLXThe Clorox Company$10.4B+0.36%